Skip to main content

Table 1 Demographics and comorbidities of patients with COVID-19

From: Associated risk factors with disease severity and antiviral drug therapy in patients with COVID-19

Variables All Patients (n = 550) Severe (n = 178) Non-severe (n = 372) p value
Age, years, n (%)
  < 44 103 (18.7%) 13 (7.3%) 90 (24.2%) < 0.001
 45–59 170 (30.9%) 36 (20.2%) 134 (36.0%) < 0.001
  ≥ 60 277 (50.4%) 129 (72.5%) 148 (39.8%) < 0.001
Sex, n (%)
 Female 292 (53.1%) 74 (41.6%) 218 (58.6%) < 0.001
 Male 258 (46.9%) 104 (58.4%) 154 (41.4%) < 0.001
Source of transmission, n (%)
 None 342 (62.2%) 144 (80.9%) 198 (53.2%) < 0.001
 Contact history with diagnosed patients 170 (30.9%) 22 (12.4%) 148 (39.8%) < 0.001
 Recent visit of COVID-19 designated hospitals 38 (6.9%) 12 (6.7%) 26 (7.0%) < 0.001
Comorbidity, n (%)
 Hypertension 184 (33.5%) 81 (45.5%) 103 (27.7%) < 0.001
 Diabetes 77 (14.0%) 37 (20.8%) 40 (10.8%) 0.002
 Cardiovascular disease 56 (10.2%) 26 (14.6%) 30 (8.1%) 0.018
 Malignancy 23 (4.2%) 13 (7.3%) 10 (2.7%) 0.011
 Cerebrovascular disease 20 (3.6%) 10 (5.6%) 10 (2.7%) 0.086
 Chronic pulmonary disease 18 (3.3%) 7 (3.9%) 11 (3.0%) 0.547
 Chronic liver disease 15 (2.7%) 4 (2.2%) 11 (3.0%) 0.843
 Hyperlipidemia 10 (1.8%) 5 (2.8%) 5 (1.3%) 0.229
  1. Data are shown as median (IQR) or n (%). ARDS Acute respiratory distress syndrome, CMV Cytomegalovirus. EBV Epstein-Barr virus